Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.

Acinetobacter baumannii is an opportunistic pathogen, causing infections mainly in patients in intensive care units where the extensive use of antimicrobial agents can select for the emergence of multiresistant strains. In fact, since strains resistant to all antimicrobial agents have been reported, A. baumannii is considered the paradigm of multiresistant bacteria. Both acquired and intrinsic resistance can contribute to multiresistance. The ability to acquire multidrug resistance can be due to either the acquisition of genetic elements carrying multiple resistant determinants or mutations affecting the expression of porins and/or efflux pump(s), which can affect unrelated antimicrobial agents. Meanwhile, intrinsic resistance can be generated by the interplay of decreased permeability and constitutive expression of active efflux systems and it too can affect unrelated antimicrobial agents. This review is focused on the current knowledge of porins and efflux pump(s) in this microorganism.

[1]  L. Donowitz,et al.  The Inanimate Environment of an Intensive Care Unit as a Potential Source of Nosocomial Bacteria: Evidence for Long Survival of Acinetobacter calcoaceticus , 1989, Infection Control & Hospital Epidemiology.

[2]  Y. Nitzan,et al.  Molecular and Structural Characterization of the HMP-AB Gene Encoding a Pore-Forming Protein from a Clinical Isolate of Acinetobacter baumannii , 2003, Current Microbiology.

[3]  E. Giralt,et al.  Proteomic analysis of a fraction enriched in cell envelope proteins of Acinetobacter baumannii , 2006, Proteomics.

[4]  G. Rossolini,et al.  Novel Acquired Metallo-β-Lactamase Gene, blaSIM-1, in a Class 1 Integron from Acinetobacter baumannii Clinical Isolates from Korea , 2005, Antimicrobial Agents and Chemotherapy.

[5]  M. Obara,et al.  Mechanisms of resistance to β-lactam antibiotics in Acinetobacter calcoaceticus , 1991 .

[6]  M. Casewell,et al.  The survival of Acinetobacter calcoaceticus inoculated on fingertips and on formica. , 1990, The Journal of hospital infection.

[7]  M. Biendo,et al.  Epidemiological Study of an Acinetobacter baumannii Outbreak by Using a Combination of Antibiotyping and Ribotyping , 1999, Journal of Clinical Microbiology.

[8]  L. Peixe,et al.  Molecular characterization of bla(IMP-5), a new integron-borne metallo-beta-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal. , 2002, FEMS microbiology letters.

[9]  W. Noble,et al.  A note on the gram negative bacilli of human skin. , 1970, Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research.

[10]  L. Dijkshoorn,et al.  Distribution and in-vitro transfer of tetracycline resistance determinants in clinical and aquatic Acinetobacter strains. , 2000, Journal of medical microbiology.

[11]  Y. Nitzan,et al.  Isolation and characterization of heat-modifiable proteins from the outer membrane of Porphyromonas asaccharolytica and Acinetobacter baumannii. , 1999, Anaerobe.

[12]  P. Higgins,et al.  Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii. , 2004, Journal of Antimicrobial Chemotherapy.

[13]  Á. Pascual,et al.  Prevalencia de los genes tetA y tetB como mecanismo de resistencia a tetraciclina y minociclina en aislamientos clínicos de Acinetobacter baumannii , 2006 .

[14]  D. Vallenet,et al.  Channel Formation by CarO, the Carbapenem Resistance-Associated Outer Membrane Protein of Acinetobacter baumannii , 2005, Antimicrobial Agents and Chemotherapy.

[15]  K. Barker.  Antibiotic resistance: a current perspective. , 1999, British journal of clinical pharmacology.

[16]  J. Ruiz,et al.  Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates. , 2002, The Journal of antimicrobial chemotherapy.

[17]  Marilyn Roberts,et al.  Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance , 2001, Microbiology and Molecular Biology Reviews.

[18]  J. Ruiz,et al.  Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  J. Vila,et al.  [Prevalence of the tetA and tetB genes as mechanisms of resistance to tetracycline and minocycline in Acinetobacter baumannii clinical isolates]. , 2006, Enfermedades infecciosas y microbiologia clinica.

[20]  J. Vila,et al.  Type 1 Integrons in Epidemiologically Unrelated Acinetobacter baumannii Isolates Collected at Spanish Hospitals , 2004, Antimicrobial Agents and Chemotherapy.

[21]  A. von Graevenitz,et al.  Search for Acinetobacter calcoaceticus subsp. anitratus: enrichment of fecal samples , 1978, Journal of clinical microbiology.

[22]  J. Weissenbach,et al.  Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii , 2006, PLoS genetics.

[23]  G. Bou,et al.  Cloning and Functional Analysis of the Gene Encoding the 33- to 36-Kilodalton Outer Membrane Protein Associated with Carbapenem Resistance in Acinetobacter baumannii , 2005, Antimicrobial Agents and Chemotherapy.

[24]  G. Rossolini,et al.  Molecular Characterization of Integrons in Epidemiologically Unrelated Clinical Isolates of Acinetobacter baumannii from Italian Hospitals Reveals a Limited Diversity of Gene Cassette Arrays , 2002, Antimicrobial Agents and Chemotherapy.

[25]  J. Chen,et al.  AbeM, an H+-Coupled Acinetobacter baumannii Multidrug Efflux Pump Belonging to the MATE Family of Transporters , 2005, Antimicrobial Agents and Chemotherapy.

[26]  L. Piddock.  Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria , 2006, Clinical Microbiology Reviews.

[27]  J. Ruiz,et al.  Outbreak of Infection With Acinetobacter Strain RUH 1139 in an Intensive Care Unit , 2006, Infection Control & Hospital Epidemiology.

[28]  E. Ron,et al.  The Acinetobacter outer membrane protein A (OmpA) is a secreted emulsifier. , 2006, Environmental microbiology.

[29]  L. Dijkshoorn,et al.  Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. , 2004, Journal of medical microbiology.

[30]  J. Pagés,et al.  Identification of an OprD homologue in Acinetobacter baumannii. , 2005, Journal of proteome research.

[31]  M. Kaufmann,et al.  Detection and Typing of Integrons in Epidemic Strains of Acinetobacter baumannii Found in the United Kingdom , 2005, Journal of Clinical Microbiology.

[32]  K. Poole.  Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria. , 2002, Current pharmaceutical biotechnology.

[33]  I. Tager,et al.  Prevalence of gram-negative rods in the normal pharyngeal flora. , 1975, Annals of internal medicine.

[34]  C. Carlier,et al.  Transferable plasmid-mediated antibiotic resistance in Acinetobacter. , 1983, Plasmid.

[35]  J. Ruiz,et al.  Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii. , 2003, The Journal of antimicrobial chemotherapy.

[36]  P. Henderson,et al.  Expression, purification and properties of multidrug efflux proteins. , 2000, Biochemical Society transactions.

[37]  E Bergogne-Bérézin,et al.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features , 1996, Clinical microbiology reviews.

[38]  F. Fernández-Cuenca,et al.  Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. , 2003, The Journal of antimicrobial chemotherapy.

[39]  Somerville Da,et al.  A note on the gram negative bacilli of human skin. , 1970 .

[40]  J. Vila.  Mechanisms of antimicrobial resistance in Acinetobacter baumannii , 1998 .

[41]  J. Ariza,et al.  Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  L. Tamm,et al.  The Outer Membrane Protein OmpW Forms an Eight-stranded β-Barrel with a Hydrophobic Channel* , 2006, Journal of Biological Chemistry.

[43]  A. Viale,et al.  Acquisition of Resistance to Carbapenems in Multidrug-Resistant Clinical Strains of Acinetobacter baumannii: Natural Insertional Inactivation of a Gene Encoding a Member of a Novel Family of β-Barrel Outer Membrane Proteins , 2005, Antimicrobial Agents and Chemotherapy.

[44]  H. Nikaido.  Molecular Basis of Bacterial Outer Membrane Permeability Revisited , 2003, Microbiology and Molecular Biology Reviews.

[45]  S. Magnet,et al.  Resistance-Nodulation-Cell Division-Type Efflux Pump Involved in Aminoglycoside Resistance in Acinetobacter baumannii Strain BM4454 , 2001, Antimicrobial Agents and Chemotherapy.

[46]  J. Ruiz,et al.  Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates. , 2002, The Journal of antimicrobial chemotherapy.

[47]  P. Courvalin,et al.  Expression of the RND-Type Efflux Pump AdeABC in Acinetobacter baumannii Is Regulated by the AdeRS Two-Component System , 2004, Antimicrobial Agents and Chemotherapy.

[48]  J. Heritage,et al.  Survival of Acinetobacter baumannii on Dry Surfaces: Comparison of Outbreak and Sporadic Isolates , 1998, Journal of Clinical Microbiology.

[49]  T. Nakae,et al.  Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. , 1991, The Journal of antimicrobial chemotherapy.

[50]  G. Bou,et al.  Characterization of a Nosocomial Outbreak Caused by a Multiresistant Acinetobacter baumannii Strain with a Carbapenem-Hydrolyzing Enzyme: High-Level Carbapenem Resistance inA. baumannii Is Not Due Solely to the Presence of β-Lactamases , 2000, Journal of Clinical Microbiology.